维普期刊资源整合服务平台（V6.5）

119篇 您的检索式：作者名="Larrue"

选中清除导出查看参考文献查看引证文献引用追踪共6页首页上一页第1页下一页末页 /6 跳转

	题名	作者	年代	出处	被引量
1	Trancranial ultrasound combined with intravenous microbubbles and tissue plasminogen activator for acute ischemic stroke:a randomized controlled study显示文摘	Larrue V Viguier A Arnaud C	2007	Stroke2007，38，：	1
2	Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombi-nant tissue plasminogen activator:A secondary analysis of the European-Australa-sian Acute Stroke Study (ECASS II)显示文摘	Larrue V von Kummer RR Muller A Bluhmki E		0，，：	1
3	Ntrathecal xenogeneic chromafin cell grafts reduce nociceptive behavior in a rodent tonic pain model显示文摘	Sol JC Sallerin B Larrue S		0，，02：	1
4	MHC class Ⅱ DRB1 gene polymorphism in the pathogenesis of Maedi-Visna and pulmonary adenocarcinoma viral diseasesin sheep显示文摘	Amaia Larrus Kain Esmeralda Minguijon Koldo Garc-ia Etxebarri	2010	Immunogenetics2010，62，：	1
5	Baroreflex Sensitivity Is Impaired in Bilateral Carotid Atherosclerosis显示文摘	Nathalie Nasr Anne Pavy-Le Vicent Larrue		0，，：	1
6	Risk Factors for Severe Hemorrhagic Transformation in Ischemic Stroke Patients Treated With Recombinant Tissue Plasminogen Activator: a secondary analysis of the European-Australasian Acute Stroke Study ( ECASS Ⅱ) 显示文摘	Larrue V Kummer RR Mfiller A	2001	Stroke2001，32，2：	1
7	Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator:a secondary analysis of the European-Australasian Acute Stroke Study (ECASS Ⅱ)显示文摘	von Kummer RR Müller A	2001	Stroke2001，32，：	1
8	Asscciation of hyperdense middle cerebral artery sign with clinical outcome in patients treated with tissue plasminogen activator 显示文摘	Manelfe C Larrue V Von-Kummer R	1999	Stroke1999，30，：	1
9	Hemorrhag ic transformation in acute ischemic stroke: potential contributing factors in the ECASS study显示文摘	Larrue V von Kummer R del Zoppo G	1999	Stroke1999，28，：	1
10	Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator, a secondary analysis of the European-Astralilasian acute stroke study(ECASS II)显示文摘	Larrue V von Kummer R Muller A	2001	Stroke2001，32，2：	1
11	Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS Ⅱ ) 显示文摘	Larrue V von Kummer R R Muller A	2001	Stroke2001，32，2：	1
12	Precise frequency spacing in photon-ic crystal DFB laser arrays显示文摘	Alexandre Larrue Olivier Bouchard Antoine Mon-mayrant	2008	IEEE PhotonicsTechnoligy Letters2008，20，24：	1
13	Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study ( ECASS lI ) 显示文摘	Larrue V von Kummer RR MUller A	2001	Stroke2001，32，2：	1
14	Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator:a secondary analysis of the European-Australasian Acute Stroke Study(ECASS II)显示文摘	LARRUE V VON KUMMER R R MVLLER A	2001	Stroke2001，32，2：	1
15	Association of hyperdense middle cerebral artery sign with clinical outcome in patients treat with tissue plas minogen activator显示文摘	Manelfe C Larrue V Von Kummer R	1999	Stroke1999，30，：	1
16	Quantification of the expression of muhidrug resistancerelated genes in human tumour cell lines grown with free doxorubicin or doxorubicin encapsulated in polyisohexylcyanoacrylate nanospheres 显示文摘	LAVRAND A LAROCHE-CLARY A LARRUE A	2004	Anticancer Res2004，24，6：	1
17	Etiologic investigation of ischemic stroke in young adults显示文摘	Larrue V Berhoune N Massabuau P	2011	Neurology2011，76，23：	1
18	Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the european -australasian acute stroke study (ECASS II) 显示文摘	LARRUE V VON KUMMER R R MULLER A	2001	Stroke2001，32，43：	1
19	Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study ( ECASS I1 ) 显示文摘	Larrue V yon Kummer RR Muller A	2001	Stroke2001，32，：	1
20	Hemorrhagic transformation in acute ischemic stroke:potential contributing factors in the ECASS study显示文摘	Larrue V yon Kummer R del Zoppo G	1999	Stroke1999，28，：	1

返回顶部每页显示：

共6页首页上一页第1页下一页末页 /6 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示